GB0922537D0 - Pharmaceutical preparation - Google Patents

Pharmaceutical preparation

Info

Publication number
GB0922537D0
GB0922537D0 GBGB0922537.6A GB0922537A GB0922537D0 GB 0922537 D0 GB0922537 D0 GB 0922537D0 GB 0922537 A GB0922537 A GB 0922537A GB 0922537 D0 GB0922537 D0 GB 0922537D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0922537.6A
Other versions
GB2476494A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norwich Pharma Technologies Ltd
Original Assignee
Norwich Pharma Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharma Technologies Ltd filed Critical Norwich Pharma Technologies Ltd
Priority to GB0922537A priority Critical patent/GB2476494A/en
Publication of GB0922537D0 publication Critical patent/GB0922537D0/en
Priority to PCT/GB2010/052210 priority patent/WO2011077169A2/en
Publication of GB2476494A publication Critical patent/GB2476494A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
GB0922537A 2009-12-24 2009-12-24 Formulation for the sublingual delivery of sufentanil Withdrawn GB2476494A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0922537A GB2476494A (en) 2009-12-24 2009-12-24 Formulation for the sublingual delivery of sufentanil
PCT/GB2010/052210 WO2011077169A2 (en) 2009-12-24 2010-12-23 Pharmaceutical preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0922537A GB2476494A (en) 2009-12-24 2009-12-24 Formulation for the sublingual delivery of sufentanil

Publications (2)

Publication Number Publication Date
GB0922537D0 true GB0922537D0 (en) 2010-02-10
GB2476494A GB2476494A (en) 2011-06-29

Family

ID=41716886

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0922537A Withdrawn GB2476494A (en) 2009-12-24 2009-12-24 Formulation for the sublingual delivery of sufentanil

Country Status (2)

Country Link
GB (1) GB2476494A (en)
WO (1) WO2011077169A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2487007B (en) * 2012-03-19 2013-06-05 Londonpharma Ltd COC containers and delivery devices for the sublingual administration of opioids
US20160296498A1 (en) * 2015-04-09 2016-10-13 Insys Development Company, Inc. Ketorolac Sublingual Spray Formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030190290A1 (en) * 2000-06-22 2003-10-09 Calvin Ross Pharmaceutical compositions
JP2006519770A (en) * 2003-03-11 2006-08-31 アラキス リミテッド New composition
GB0514043D0 (en) * 2005-07-08 2005-08-17 Arakis Ltd Fentanyl formulation
GB2441129B (en) * 2006-08-26 2008-11-26 Norwich Pharma Technologies Ltd Dosage Dispensing Canister
AU2008216867B2 (en) * 2007-02-09 2014-01-30 Durect Corporation Transoral dosage forms comprising sufentanil and naloxone

Also Published As

Publication number Publication date
WO2011077169A3 (en) 2012-03-15
WO2011077169A2 (en) 2011-06-30
GB2476494A (en) 2011-06-29

Similar Documents

Publication Publication Date Title
HK1231408A1 (en) Pharmaceutical composition
HK1217434A1 (en) Pharmaceutical compositions
EP2451274A4 (en) Pharmaceutical compositions
HK1169960A1 (en) Pharmaceutical formulation
EP2379077A4 (en) Pharmaceutical composition
IL215962A0 (en) Soilid preparation
ZA201104348B (en) Pharmaceutical preparation
GB0815972D0 (en) Pharmaceutical preparation
GB0922589D0 (en) Pharmaceutical compounds
EP2514422A4 (en) Elution-stabilized preparation
EP2488175A4 (en) Pharmaceutical compositions
GB0908905D0 (en) Pharmaceutical compounds
GB0922537D0 (en) Pharmaceutical preparation
GB0919650D0 (en) Pharmaceutical composition
EP2668961A4 (en) Combined pharmaceutical preparation
GB0906971D0 (en) Pharmaceutical preparation
GB201115173D0 (en) Pharmaceutical preparation
GB201115179D0 (en) Pharmaceutical preparation
GB0910772D0 (en) Pharmaceutical
PL390620A1 (en) Pharmaceutical preparation
GB0915678D0 (en) Pharmaceutical compounds
GB0913850D0 (en) Pharmaceutical compounds
GB0911699D0 (en) Pharmaceutical compounds
GB0916458D0 (en) Pharmaceutical compounds
GB0917677D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)